Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ADXS Advaxis > Detailed Quotes

ADXS Advaxis

2.150
-0.170-7.33%
Close 09/23 16:00 ET
High
2.150
Open
2.070
Turnover
3.92K
Low
2.070
Pre Close
2.320
Volume
1.84K
Market Cap
3.91M
P/E(TTM)
Loss
52wk High
44.800
Shares
1.82M
P/E(Static)
Loss
52wk Low
2.000
Float Cap
3.91M
Bid/Ask %
0.00%
Historical High
187499.985
Shs Float
1.82M
Volume Ratio
0.71
Historical Low
2.000
Dividend TTM
--
Div Yield TTM
--
P/B
0.11
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.10%
Amplitude
3.45%
Avg Price
2.128
Lot Size
1
Float Cap
3.91M
Bid/Ask %
0.00%
Historical High
187499.985
Shs Float
1.82M
Volume Ratio
0.71
Historical Low
2.000
Dividend TTM
--
P/B
0.11
Dividend LFY
--
Turnover Ratio
0.10%
Amplitude
3.45%
Avg Price
2.128
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.
CEO: Mr. Kenneth A. Berlin
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...